Cencora, Inc. (COR) vs Regeneron Pharmaceuticals, Inc. (REGN)
A side-by-side comparison of Cencora, Inc. and Regeneron Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
COR
Cencora, Inc.
$319.58HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
REGN
Regeneron Pharmaceuticals, Inc.
$695.18HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — COR vs REGN
growth of $100 · dividends reinvested · last 30yCOR +10008.5%REGN +4131.1%COR compounded faster
COR REGN
COR vs REGN: by the numbers
- •REGN is the larger company ($71.62B vs $62.18B market cap).
- •REGN trades at the lower trailing earnings multiple (16.26 vs 23.86 P/E), one valuation lens rather than an overall verdict.
- •REGN converts more revenue to profit (29.65% vs 0.78% net margin).
- •COR grew revenue faster over the past five years (10.86% vs 10.16% CAGR).
- •COR pays the higher dividend yield (0.76% vs 0.55%).
Metrics side by side
Valuation
| Metric | COR | REGN |
|---|---|---|
| P/E ratio | 23.86 | 16.26 |
| Forward P/E | 17.50 | 14.58 |
| P/S ratio | 0.18 | 4.82 |
| P/B ratio | 17.89 | 2.29 |
| PEG ratio | 7.05 | 3.38 |
| EV / EBITDA | 13.54 | 17.17 |
| FCF yield | 2.56% | 5.78% |
Profitability
| Metric | COR | REGN |
|---|---|---|
| Gross margin | 3.47% | 84.55% |
| Operating margin | 1.28% | 24.32% |
| Net margin | 0.78% | 29.65% |
| ROE | 75.01% | 14.08% |
| ROIC | 13.23% | 8.51% |
Dividends
| Metric | COR | REGN |
|---|---|---|
| Dividend yield | 0.76% | 0.55% |
| Payout ratio | 29.30% | 8.45% |
Growth (annualized)
| Metric | COR | REGN |
|---|---|---|
| Revenue CAGR (5Y) | 10.86% | 10.16% |
| EPS CAGR (5Y) | 11.97% | 5.70% |
| FCF CAGR (5Y) | 3.95% | 15.42% |
| Total return CAGR (5Y) | 21.96% | 3.56% |
Frequently asked
- Which has the lower trailing P/E, COR or REGN?
- REGN has the lower trailing P/E: COR trades at 23.86 and REGN at 16.26. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, COR or REGN?
- Over the past five years, COR grew revenue faster — COR at a 10.86% CAGR versus REGN at 10.16%.
- Does COR or REGN pay a bigger dividend?
- COR yields 0.76% and REGN yields 0.55% based on trailing dividends and the latest price.
- Is COR or REGN more profitable?
- REGN runs the higher net margin — COR at 0.78% versus REGN at 29.65%.
- How have COR and REGN total returns compared?
- Over the past 10 years, COR delivered 15.80% and REGN delivered 5.44% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cencora P/E ratioRegeneron Pharmaceuticals P/E ratioCencora dividend yieldRegeneron Pharmaceuticals dividend yieldCencora ROERegeneron Pharmaceuticals ROECencora operating marginRegeneron Pharmaceuticals operating marginCencora revenue growthRegeneron Pharmaceuticals revenue growthCencora free cash flowRegeneron Pharmaceuticals free cash flow
Cencora & Regeneron Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.